Article ID Journal Published Year Pages File Type
10910784 Lung Cancer 2015 4 Pages PDF
Abstract
This is the first report on outcomes for stage II NSCLC patients receiving CRT as definitive therapy. Survival approximates stage III CRT patients from historical phase III trials. As an increasing aging population may parallel a rise in medically inoperable stage II patients, this study can provide useful information when reviewing treatment options.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study
Authors
, , ,